Every 10-Q that HEALTHY EXTRACTS INC (HYEX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HYEX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HYEX filings page.
Healthy Extracts Inc. reported strong top-line growth for the three months ended June 30, 2026, with revenue of $2,067,212 compared with $968,656 a year earlier. For the six-month period, revenue was $3,677,956 versus $1,899,935 in 2025. Gross profit for six months rose to $2,441,145, but higher operating expenses of $2,818,116 resulted in a net loss of $329,486 for the period, similar to the $331,739 loss a year earlier.
Cash increased to $189,958 as of June 30, 2026, and operating activities generated $411,983 of cash in the first half of 2026. Total assets were $32,608,849, including $26,056,515 of goodwill largely from acquisitions, while total liabilities were $10,173,158, leaving stockholders’ equity of $22,435,692.
On May 15, 2026, the company acquired Adli Gummies Inc. through its subsidiary, issuing promissory notes totaling $794,000 and equity, and arranging for its CEO to loan back 3,000,000 shares valued at $5,400,000, recorded as related-party unsecured debt. Management disclosed an accumulated deficit of $20,450,948 and stated there is substantial doubt about the company’s ability to continue as a going concern, despite more neutral recent cash flows.
Healthy Extracts Inc. reported higher sales but remained unprofitable for the three months ended March 31, 2026. Revenue rose to $1,610,744 from $931,280 a year earlier, lifting gross profit to $988,701 from $424,985. General and administrative expenses increased to $1,317,403, driven by higher advertising, consulting, salaries, and stock-based compensation. The company posted a net loss of $200,590, an improvement from a $398,860 loss, helped by a $283,019 gain from the change in fair value of derivative liabilities. Cash was $164,385 and total liabilities were $3,337,239, while accumulated deficit reached $20,322,053. Management highlights ongoing substantial doubt about the ability to continue as a going concern and plans to seek additional debt and equity financing.
Healthy Extracts Inc. (HYEX) reported Q3 2025 results and closed a transformative equity transaction. Revenue for the quarter was $917,975 versus $744,916 a year ago, but the company posted a net loss of $395,394 after higher operating expenses. For the nine months, revenue reached $2,817,910 with a net loss of $727,133.
On July 19, 2025, HYEX agreed to acquire Gummy USA LLC and issued 13,075,920 common shares, representing 77.5% of the company after the deal. Following a rescission on September 26, 2025, the merger structure was revised and the shares were re‑issued effective October 1, 2025; the $23,536,656 related amount is presented as a long‑term investment pending consolidation analysis. Shares outstanding were 16,870,868 as of September 30, 2025.
Cash was $189,452, operating cash flow used was $202,634, and derivative liabilities were $557,997. Management disclosed substantial doubt about the company’s ability to continue as a going concern within one year.